Kymera Therapeutics: A Biotech Company with a Promising Future

Friday, Aug 1, 2025 9:28 am ET1min read

Gladstone Capital Corporation will hold its Q3 2025 earnings call on August 5, 2025. Investors can participate via webcast or phone, with a replay available until August 12, 2025. The company specializes in secured loans to lower middle market US businesses.

Kymera Therapeutics: A Biotech Company with a Promising Future

Comments



Add a public comment...
No comments

No comments yet